Cancer Research UK to Double Size of Tech- Transfer Arm; US Expansion Part of Plans | GenomeWeb
Cancer Research Technology, the technology transfer company of research charity Cancer Research UK, said this month that it is doubling the size of its internal drug-discovery and -development laboratories over the next year.
 
The expansion is intended to help CRT meet the growing demand for its translational research services in the UK, and to fuel its expansion into the US, where it hopes to apply its model for commercializing early-stage cancer technologies to university-based research.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.